#Oxford

London, Apr 15 (PTI) The risk of rare blood clotting following the COVID-19 infection is around 100 times greater than normal, several times higher than it is post-vaccination or following ...

London, April 14 (PTI) A study assessing the benefits of mixing and matching coronavirus vaccines has been extended to include the Moderna and Novavax jabs.

London, Apr 6 (PTI) A trial of the Oxford/AstraZeneca COVID-19 vaccine on children has been paused while the UK's medicines regulator investigates a possible link with rare blood clots in adults.

London, Apr 3 (PTI) The UK’s medicines regulator has confirmed seven cases of blood clot-related deaths in people who received the Oxford/AstraZeneca vaccine against COVID-19, but stressed on ...

31 March
European Union health agency on Wednesday said it has found no risk factors, including age, associated with AstraZeneca COVID-19 vaccine. (Photo Credit: AFP)

  • The agency will conduct further analysis
  • Several European countries suspended the use of the vaccine citing blood clot concerns

22 March.London, UK
AstraZeneca has been collaborating with Oxford to produce COVID-19 vaccines (Photo Credit: AFP)

  • 9% of UK residents believe the AstraZeneca vaccine is not safe
  • In a survey conducted in March, 55% of Germans found the vaccine unsafe
  • No similar increases in safety fears were seen for Pfizer and Moderna